When to start medicine for gestational diabetes
Gestational Diabetes and Pharmacotherapy (GAP) – A Randomized Controlled Trial Investigating Timing of Pharmacotherapy Initiation for Patients with Gestational Diabetes
This project compares starting diabetes medicine earlier versus later in pregnancy to see which approach leads to better health for pregnant people with gestational diabetes.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Medical College of Wisconsin NIH-funded |
| Lab location | 1 site (Milwaukee, United States) |
| Project ID | NIH-11317089 on NIH RePORTER |
What this research studies
If you join, you would be followed after a gestational diabetes diagnosis while you try medical nutrition therapy and exercise, and if those measures don’t control your blood sugar you would be randomly assigned to start medicine sooner or later according to the trial plan. Your blood sugar readings, birth outcomes for your baby, and your own health and mood will be tracked through the pregnancy and delivery. The team will compare newborn complications, size at birth, and measures of maternal anxiety and depression between the groups. The goal is to find a clearer, fairer rule for when doctors should add medication so care is more consistent for people of different backgrounds.
Who could benefit from this research
Good fit: Pregnant people diagnosed with gestational diabetes, typically in the second trimester, who are initially managed with diet and exercise and could potentially need medication are the intended participants.
Not a fit: People without gestational diabetes, those with preexisting diabetes who are already on medication, or those who need immediate pharmacotherapy for medical reasons are unlikely to benefit or be eligible.
Why it matters
Potential benefit: If successful, this could lower newborn complications and create clearer guidelines so future pregnant people get the right diabetes treatment at the right time.
How similar studies have performed: Prior work and smaller studies suggested earlier medication can improve some newborn outcomes, but results are not definitive and concerns like small-for-gestational-age and effects on maternal mental health remain unresolved.
Where this research is happening
Milwaukee, United States
- Medical College of Wisconsin — Milwaukee, United States (Active)
Researchers
- Principal investigator: Palatnik, Anna — Medical College of Wisconsin
- Study coordinator: Palatnik, Anna
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.